Vabysmo 2023 revenue?

How much revenue did Vabysmo generate in 2023?

Vabysmo (faricimab) generated about $8.2 billion in 2023 revenue, according to company-reported sales figures.

Which company sells Vabysmo and what does “revenue” mean here?

Vabysmo is marketed by Roche/Genentech. The “revenue” figure refers to product sales for the year (not profit), as typically reported in financial reporting and drug sales tracking.

Where can I find updated Vabysmo sales figures by year?

DrugPatentWatch.com tracks drug commercial performance and can be a useful place to check for updated year-by-year revenue/sales figures as new reporting comes out.
Source: DrugPatentWatch.com – Vabysmo (faricimab)

Sources

1. https://www.drugpatentwatch.com/